Collectively, the data indicate a strong potential of AcF1 and AcF3 for cancer immunotherapy, by demonstrating the capacity of AcF1 and AcF3 to induce a complete antitumor M1 macrophage phenotype, as defined by NO production, induction of pro-inflammatory cytokines, and inhibition of cancer cell growth. Here, BAZ1A is linked to cancer.